Josefina Cruz Jurado

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer

Hope S. Rugo, Fabrice André, Toshinari Yamashita et al. · Annals of Oncology · 2020 · 187 citations · Full text

Medicine, Oncology, Pharmacology +15

Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group

Alessandro Gronchi, Silvia Stacchiotti, Paolo Verderio et al. · Annals of Oncology · 2016 · 132 citations · Full text

Medicine, Oncology, Surgery +17

High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial

Sandro Pasquali, Chiara Colombo, Sara Pizzamiglio et al. · European Journal of Cancer · 2018 · 85 citations

Medicine, Oncology, Surgery +17

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

Ana de Juan Ferré, Rosa Álvarez, Josefina Cruz Jurado et al. · Clinical & Translational Oncology · 2021 · 52 citations · Full text

Medicine, Oncology, Surgery +17